Abstract:Erythropoietic response is controlled not only by erythropoietin but also by iron. In addition to its role in iron delivery, transferrin also functions as a signaling molecule, with effects on both iron homeostasis and erythropoiesis. We investigated hematologic parameters, iron status and expression of key proteins, including the hepatic iron regulatory protein hepcidin and the suppressive erythroid factor Erfe , in mice subject to dietary iron deficiency with and without anemia. The acute effect of iron on these parameters was investigated by administration of exogenous iron-loaded transferrin (holoTf) in each of the mouse models. Serum iron in mice with iron deficiency (ID) is modestly lower with hematologic parameters maintained by utilization of iron stores in mice with ID. As expected, erythropoietin expression and concentration, along with marrow Erfe are unaffected in ID mice. Administration of holoTf restores serum iron and Tf saturation levels to those observed in control mice and results in an increase in hepcidin compared to ID mice not treated with holoTf. The expression of the Bmp signaling molecule Bmp6 is not significantly increased following Tf treatment in ID mice. Thus, the expression level of the gene encoding hepcidin, Hamp1 , is increased relative to Bmp6 expression in ID mice following treatment with holoTf, leading us to speculate that Tf saturation may influence Bmp sensitivity. In mice with iron deficiency anemia (IDA), decreased hematologic parameters were accompanied by pronounced decreases in serum and tissue iron concentrations, and an increase in serum erythropoietin. In the absence of exogenous holoTf, the greater serum erythropoietin was not reflected by an increase in marrow Erfe expression. HoloTf administration did not acutely change serum Epo in IDA mice. Marrow Erfe expression was, however, markedly increased in IDA mice following holoTf, plausibly accounting for the lack of an increase in Hamp1 following holoTf treatment in the IDA mice. The increase in Erfe despite no change in erythropoietin suggests that Tf acts to increase erythropoietin sensitivity. These observations underscore the importance of Tf in modulating the erythropoietic response in recovery from iron deficiency anemia, with implications for other stress erythropoiesis conditions.

Erythroferrone structure, function, and physiology: Iron homeostasis and beyond

Erythroferrone in focus: emerging perspectives in iron metabolism and hematopathologies

Erythroferrone and hepcidin levels in children with iron deficiency anemia

EPO-dependent Induction of Erythroferrone Drives Hepcidin Suppression and Systematic Iron Absorption under Phenylhydrazine-Induced Hemolytic Anemia.

Early erythroferrone levels can predict the long‐term haemoglobin responses to erythropoiesis‐stimulating agents

Physiological focus on the erythropoietin-hepcidin-ferroportin axis

Structure, Function and Clinical Significance of Transferrin Receptors

Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia

Understanding iron homeostasis in MDS: the role of erythroferrone

Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis

Increased erythroferrone levels in malarial anaemia

Heme-Regulated Eif2 Alpha Kinase (Hri) Is Required For Translational Regulation And Survival Of Erythroid Precursors In Iron Deficiency

Iron metabolism and iron disorders revisited in the hepcidin era

Erythropoietin enhances iron bioavailability in HepG2 cells by downregulating hepcidin through mTOR, C/EBPα and HIF-1α

Extrahepatic deficiency of transferrin receptor 2 is associated with increased erythropoiesis independent of iron overload

Physiological and Pathophysiological Mechanisms of Hepcidin Regulation: Clinical Implications for Iron Disorders

Effects of Exogenous Transferrin on the Regulation of Iron Metabolism and Erythropoiesis in Iron Deficiency With or Without Anemia

Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review.

Normal and dysregulated crosstalk between iron metabolism and erythropoiesis

Ironing erythroid cells takes FLG1 and ERFE to tango

Essential but toxic: controlling the flux of iron in the body.